Ozlem Aydin

Publications (2)3.35 Total impact

• Article: Diffuse involvement of the heart and great vessels in primary cardiac lymphoma.

  Aysel Aydin Kaderli, Ibrahim Baran, Ozlem Aydin, Murat Bicer, Tayyar Akpinar, Fahir Ozkalemkas, Dilek Yesilbursa, Sumeyye Gullulu
  [show abstract] [hide abstract]
  ABSTRACT: Primary cardiac lymphoma (PCL) is an extremely rare disorder. In this report, a 57-year-old male with diffuse large B-cell lymphoma involving the heart and great vessels is presented. Trans-thoracic echocardiography was the first modality used to establish the diagnosis. Fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) showed diffuse increased metabolic activity of the heart walls and hypermetabolic lesions occupying cardiac chambers in some areas. The patient underwent systemic chemotherapy, and after 13 days, a marked regression of the tumour mass was evident based on echocardiographic examination. After completing six R-CHOP chemotherapy treatments, PET imaging was planned to control the residual mass, but the patient was intubated due to pneumonia that developed after the sixth chemotherapy session and subsequently died due to sepsis.
  European Heart Journal – Cardiovascular Imaging 09/2009; 11(1):74-6. · 2.32 Impact Factor
• Article: Successful treatment of saphenous venous graft thrombus by tirofiban infusion.

  Tunay Sentürk, Aysel Aydin Kaderli, Ozlem Aydin, Dilek Yeşilbursa, Osman Akin Serdar
  [show abstract] [hide abstract]
  ABSTRACT: A 60-year old man with a history of coronary-artery bypass grafting presented with symptoms of acute coronary syndrome. Coronary angiography revealed a huge intraluminal thrombus in the saphenous vein graft to the second obtuse marginal branch of the left circumflex artery. A glycoprotein IIb/IIIa inhibitor (tirofiban) was administered intravenously. Two days later, thrombus dissolution and Thrombolysis In Myocardial Infarction (TIMI) grade 3 flow were evident on repeat coronary angiography. Glycoprotein IIb/IIIa inhibitors may be useful in a thrombus-laden saphenous-vein graft.
  Heart & lung: the journal of critical care 39(3):237-9. · 1.04 Impact Factor